Showing results (241-250 of 672) with videos related to
Sort By:
Pageof 68
Journal of Neural Transmission. Supplementum|January 1, 1995
The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissueJ Kornhuber, B Herr, J Thome, et al.Journal of Neural Transmission. Supplementum|August 30, 2003
Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's diseaseM Gerlach, K Double, H Reichmann, et al.Journal of Neural Transmission. Supplementum|January 1, 1992
Neurotoxicity and neuroprotection in Parkinson's diseaseK W Lange, M B Youdim, P RiedererClinical Pharmacology and Therapeutics|December 1, 1994
Biochemical actions of l-deprenyl (selegiline)K W Lange, P Riederer, M B YoudimJournal of Neural Transmission|January 1, 1983
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizzinessW Birkmayer, G Birkmayer, H Lechner, et al.Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.Biological Psychiatry|February 1, 1992
3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspectsN Wodarz, J Fritze, J Kornhuber, et al.Journal of Neural Transmission. Supplementum|January 1, 1994
Amantadine and memantine are NMDA receptor antagonists with neuroprotective propertiesJ Kornhuber, M Weller, K Schoppmeyer, et al.European Journal of Pharmacology|May 11, 1989
Isoelectric focusing of monoamine oxidase subtypes as identified by MAO inhibitorsJ Fritze, P Koronakis, C Konradi, et al.Acta Neuropathologica|June 23, 1999
Apoptosis of T lymphocytes in acute disseminated encephalomyelitisJ Bauer, C Stadelmann, C Bancher, et al.Pageof 68